Medytox Solutions, Inc.: 10-Q/A filed 2011-09-16
What Medytox Solutions, Inc. reported in its quarterly report amendment filed 2011-09-16 (fiscal Q2 2011): 15 published measures, 40 facts as tagged in accession 0001093661-11-000016.
This is an amendment. Values here are as tagged in the amendment; the original filing has its own page.
This filing
- Form
- 10-Q/A (quarterly report amendment)
- Filed
- 2011-09-16
- Fiscal period
- fiscal Q2 2011
- Accession
- 0001093661-11-000016 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Medytox Solutions, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 16,211 | USD | |
| At 2010-12-31 | 20,867 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | -468,192 | USD | |
| At 2010-12-31 | -431,162 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 174 | USD | |
| At 2010-12-31 | 9,330 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | -10,453 | USD | 91 |
| 2011-01-01 to 2011-06-30 | -50,030 | USD | 181 |
| 2010-04-01 to 2010-06-30 | -118,978 | USD | 91 |
| 2010-01-01 to 2010-06-30 | -159,111 | USD | 181 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-06-30 | -9,156 | USD | 181 |
| 2010-01-01 to 2010-06-30 | -42,380 | USD | 181 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | -1,225,015 | USD | |
| At 2010-12-31 | -1,174,985 | USD |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 7,537 | USD | |
| At 2010-12-31 | 11,537 | USD |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | -10,453 | USD | 91 |
| 2011-01-01 to 2011-06-30 | -50,030 | USD | 181 |
| 2010-04-01 to 2010-06-30 | -118,599 | USD | 91 |
| 2010-01-01 to 2010-06-30 | -158,229 | USD | 181 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 8,674 | USD | |
| At 2010-12-31 | 9,330 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | 0 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 0 | USD | 181 |
| 2010-04-01 to 2010-06-30 | -379 | USD | 91 |
| 2010-01-01 to 2010-06-30 | -882 | USD | 181 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 484,403 | USD | |
| At 2010-12-31 | 452,029 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | 10,563 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 54,796 | USD | 181 |
| 2010-04-01 to 2010-06-30 | 125,090 | USD | 91 |
| 2010-01-01 to 2010-06-30 | 170,322 | USD | 181 |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | -10,453 | USD | 91 |
| 2011-01-01 to 2011-06-30 | -50,030 | USD | 181 |
| 2010-04-01 to 2010-06-30 | -118,978 | USD | 91 |
| 2010-01-01 to 2010-06-30 | -159,111 | USD | 181 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-06-30 | 4,000 | USD | 181 |
| 2010-01-01 to 2010-06-30 | 750 | USD | 181 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-06-30 | 28,500 | USD | 181 |
| 2010-01-01 to 2010-06-30 | 18,220 | USD | 181 |
Inspect the source
- Entity
- Medytox Solutions, Inc. / CIK 0001374536
- Captured
- SEC response SHA-256
27557d1687b392f65b1f7154cde4a118410947e5e6de2414106856cd23312b91
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001374536.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))